Everise Names Kevin Bottoms as Chief Revenue Officer
AUSTIN, Texas, Feb. 22, 2022 /PRNewswire/ -- Everise, a technology-driven customer experience (CX) service provider, announced today the appointment of Kevin Bottoms as Chief Revenue Officer. As an accomplished leader in the technology and managed services sector, Bottoms will focus on enhancing the company's go-to-market strategies, innovating processes, and driving new client partnerships to increase revenue for Everise. ...
SPARK™ CLEAR ALIGNERS NEW RELEASE 12 GIVES DOCTORS MORE CONTROL, FLEXIBILITY AND EFFICIENCY IN CASE SETUP AND TREATMENT PLANNING
ENHANCED PATIENT ROOT VISUALIZATION, NOTABLE CLINICAL IMPROVEMENTS BREA, Calif., Feb. 22, 2022 /PRNewswire/ -- Ormco Corporation, a global leader of orthodontic solutions, today announced its Spark Clear Aligners Release 12, offering industry-leading clinical enhancements, product optimization, and case-planning improvements to give doctors more flexibility, efficiency, and control. Spark Release 12 -...
First Japanese Institution to Utilize SOPHiA GENETICS’ Myeloid Plus Solution
BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with Hiroshima University, one of the top public universities in Hiroshima City, Japan, to support their molecular profiling by next-generation sequencing (NGS) in investigating the pathogenic variants causing different blood cancer disorders. Hiroshima...
Gracell Biotechnologies Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform
SUZHOU, China, and PALO ALTO, Calif., Feb. 22, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced multiple advancements of its TruUCAR platform, the Company's proprietary technology...
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP
BEIJING, Feb. 22, 2022 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the first patient has been dosed in Phase II clinical trial of its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for the treatment of primary immune thrombocytopenia (ITP) in China. Primary immune thrombocytopenia (ITP), also referred to as idiopathic thrombocytopenic purpura, is an...
4D IMAGING RADAR LEADER VAYYAR EXPANDS GLOBAL FOOTPRINT WITH NEW JAPAN OFFICE
- Vayyar Imaging's new office will open in Tokyo, Japan in February, supporting the technology company's growth strategy in the key senior care and automotive markets - Vayyar's touchless senior care technology is deployed in facilities and private homes around the world, providing activity monitoring that supports automatic fall detection and a wide range of behavioral insights - Hand-picked team of...
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 – Conference Call to Follow
SHANGHAI, Feb. 22, 2022 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021, before the U.S. market opens...
Nippon Express Obtains GDP Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, Feb. 22, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained Good Distribution Practice (GDP) certification, effective January 11, for NX-PHARMA Logistics Hub Kansai Airport, a temperature-controlled facility being operated inside the international cargo area of Kansai International Airport, evidencing its compliance with GDP standards for...
Nanoform 4Q and full year 2021 report: accelerating GMP growth
HELSINKI, Feb. 22, 2022 /PRNewswire/ -- The strong momentum continues: first two customer GMP projects signed, full-year gross margin exceeds 2025 target, the rapid growth in orders received and revenue recognized accelerates further, the first clear signs of economics of scale emerges, while the near-term focus shifts to triple our GMP capacity and thereafter being able to run many...
Winner Silver Alginate Dressing has Obtained 510K Code in the USA
SHENZHEN, China, Feb. 22, 2022 /PRNewswire/ -- Recently, the silver alginate dressing of Winner Medical (300888.SZ) receives U.S. FDA market access (510K Number: K202982), marking that this product has obtained the qualification to get into the access US market and Winner Medical will further expand its business in North America. It...
